It's another miss for Theranos, as the Silicon Valley start-up has voided the results of its 2014 to 2015 blood tests conducted on the Edison machines. What are the implications on patients' health decisions in the last two years?
It's another miss for Theranos, as the Silicon Valley start-up has voided the results of its 2014 to 2015 blood tests conducted on the Edison machines. What are the implications on patients' health decisions in the last two years?
Share this Article
Recommended